Eagle Pharmaceuticals, Inc. Receivables, Long-term Contracts or Programs
Eagle Pharmaceuticals, Inc. had Receivables, Long-term Contracts or Programs of $1.75 million as of 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesLongTermContractsOrPrograms · last filed 2021-11-09
- 2021-09-30: Receivables, Long-term Contracts or Programs $1.75M.
- 2020-12-31: Receivables, Long-term Contracts or Programs $439.00K.
- 2020-09-30: Receivables, Long-term Contracts or Programs $5.00M.
- 2019-12-31: Receivables, Long-term Contracts or Programs $0.00.
| Period end | Receivables, Long-term Contracts or Programs |
|---|---|
| 2021-09-30 | $1.75M 10-Q · filed 2021-11-09 |
| 2020-12-31 | $439.00K 10-Q · filed 2021-11-09 |
| 2020-09-30 | $5.00M 10-Q · filed 2020-11-02 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-02 |